undamentalytics Newsletter

Funds (13F)

Cevian Capital Ii Gp Ltd

Backtest from 5 Feb 2016 to 2 Nov 2026 · weekly · hypothetical

Watch this strategy
Return a year
+7.7%
S&P 500 +15.7%
Last 12 months
+15.5%
S&P 500 +12.1%
Sharpe ratio
0.31
S&P 500 0.81
Biggest drop
−62.9%
S&P 500 −31.8%
$5.0k$10.0k$20.0k$40.0k 201620182020202220242026 $47.9k$22.2k
Cevian Capital Ii Gp LtdS&P 500 $10,000 in Cevian Capital Ii Gp Ltd from 5 Feb 2016 against the S&P 500 (total return) over the same dates, marked weekly, log scale. Hypothetical: before taxes and trading costs.

About

Copies Cevian Capital Ii Gp Ltd's quarterly 13F holdings in the companies we cover, weighted by reported value: it buys on the first trading day after each 13F is filed (up to 45 days after the quarter) and holds until the next filing. A 13F shows long US-listed positions only, at the quarter's end, so this misses shorts, cash, bonds, non-US holdings and trading within the quarter.

Cevian Capital Ii Gp Ltd's 13F holdings →

Key statistics

MeasureStrategyS&P 500
Return a year (compound)+7.7%+15.7%
Total return+122%+379%
Last 12 months+15.5%+12.1%
Last 3 months−4.7%—
Last month+5.8%—
This year so far−0.4%—
Volatility a year32.5%16.6%
Sharpe ratio0.310.81
Biggest drop−62.9%−31.8%
Beta to the S&P 5001.231.00
Alpha a year (t-statistic)−6.5% (−0.85)—
Share of weeks up42%—

Sharpe ratio uses returns above the 3-month Treasury bill rate. Alpha is the yearly return left after allowing for the strategy's exposure to the S&P 500 (CAPM); a t-statistic below about 2 means it cannot be told apart from luck.

Insights

CompanyWeightHeld sinceReturn since
UBS64.5%——
ALV19.8%——
CRH15.7%——

Weighted by reported value in the latest 13F, held until the next filing.

PeriodReturn a yearS&P 500SharpeS&P 500Biggest dropBetaAlpha (t)
Whole backtest5 Feb 2016 to 2 Nov 2026+7.7%+15.7%0.310.81−62.9%1.23−6.5% (−0.85)
2018 onwards5 Jan 2018 to 2 Nov 2026+9.4%+13.9%0.350.66−62.9%1.29−2.8% (−0.30)
Last three years3 Nov 2023 to 2 Nov 2026+29.3%+21.8%1.021.16−22.1%1.22+4.3% (0.45)
Last year7 Nov 2025 to 2 Nov 2026+15.7%+14.2%0.600.84−22.1%1.11+1.8% (0.10)
DateCompanyAction
15 Nov 2024UBSBought
15 Nov 2024CRHBought
15 Nov 2024ALVBought

Dated at the rebalance that made the change.

None recorded.

Dated at the rebalance that made the change.

Backtests are hypothetical and use today's listed companies only, which flatters results. Past performance does not predict future returns. This is research, not investment advice. How we backtest